J. Mariya Jothi, A. Jayaprakash
J. Mariya Jothi1, A. Jayaprakash2*
1M.Sc. Student, PG and Research Department of Biochemistry, Sacred Heart College (Autonomous), Tirupattur- 635601, Tirupattur District, Tamil Nadu, India.
2Assistant Professor, PG and Research Department of Biochemistry, Sacred Heart College (Autonomous), Tirupattur - 635601, Tirupattur District, Tamil Nadu, India.
Volume - 15,
Issue - 5,
Year - 2022
Enteromorpha compressa seaweeds were evaluated for its in vitro anticancer activity on ovarian cancer cell line. Enteromorpha compressa was collected in and around Mandapam Coast, Rameshwaram, Ramanathapuram District, Tamil Nadu and extracted with 100mL of ethanol using Soxhlet apparatus. The extract showed the presence of phytochemical constituents like alkaloids, saponins, tannins, glycosides, flavonoids, phenols, steroids, terpenoids, quinones and proteins. Total flavonoid content in the chloroform bark extract, using the calibration curve was found to be 1.73mg of quercetin equivalents/g dry weight of the extract. Seaweed extract was subjected to Thin Layer Chromatography for flavonoid detection. The IC50 value of E. compressa extract was found to be 37.68µg/mL against PA1 ovarian cell line compared to the anticancer drug Cisplatin. Hence, the extract may be further analyzed for its potential pharmacological activity against ovarian cancer.
Cite this article:
J. Mariya Jothi, A. Jayaprakash. Phytochemical Analysis and In Vitro Anticancer Activity of Enteromorpha compressa against Ovarian Cancer. Research Journal of Pharmacy and Technology. 2022; 15(5):1943-7. doi: 10.52711/0974-360X.2022.00323
J. Mariya Jothi, A. Jayaprakash. Phytochemical Analysis and In Vitro Anticancer Activity of Enteromorpha compressa against Ovarian Cancer. Research Journal of Pharmacy and Technology. 2022; 15(5):1943-7. doi: 10.52711/0974-360X.2022.00323 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-5-5
1. Vijayalakshmi K. Assessment of Depression among Cancer Patients. Asian Journal of Nursing Education and Research 2018; 8 (1):11-14. DOI: 10.5958/2349-2996.2018.00004.6
2. Mr. Sachina Banur Tippegowda. A Case Study on Ovarian Cancer–Palliative Perspective. Journal of Nursing Education and Research 2015; 5(3):446-448. DOI: 10.5958/2349-2996.2015.00090.7
3. Glushakov R. Sulin K. Semenov A. Kotiv B. Tapilskaya N. The Effect on the Altered Thyroid Status for Ovarian Tumor Xenografts in Rats. Research Journal of Pharmacy and Technology 2018; 11(6):2317-2322. DOI: 10.5958/0974-360X.2018.00430.4
4. Baker LAA. AI Obeady AHM. Relationship of Fatty acid composition and some Biochemical parameters in Serum for women Ovarian Cancer patient. Research Journal of Pharmacy and Technology 2019; 12(9):4511-5417. DOI: 10.5958/0974-360X.2019.00777.7
5. Jarrett NM. Gloria JCR. Abirami MP. Shyam Sundar J. Radhakrishnan S. Deepa S. Abirami S. et al Cytotoxic and Apoptotic Effect of Citrus Flavonoid Naringin in Treating PA-1 Ovarian Cancer Cells. Research Journal of Pharmacy and Technology 2020; 13(9):4051-4054. DOI: 10.5958/0974-360X.2020.00716.7
6. Hussein MJ. Dr. Al-Alwany SHM. Molecular Highlighting Analysis of Mutational CDK41, CDK6 and P27 in association with Human Mammary Tumor Virus Infection in Tissues from Iraqi Female with Ovarian Tumors. Research Journal of Pharmacy and Technology 2018; 11(10):4699-4706. DOI: 10.5958/0974-360X.2018.00858.2
7. Kumbhar Swapnil, Salunkhe Vijay, Magdum Chandrakant. Targeted Drug Delivery: A Backbone for Cancer Therapy. Asian Journal of Pharmaceutical Research 2013; 3(1): 40-46.
8. Balaji EV. Tamil Selvan A. Cancer-A Historical Status, Government Regulation and Current Scenario of Socio-Economic Impact – Retrospective Study. Asian Journal of Pharmaceutical Research 2018; 8(3): 133-135. DOI: 10.5958/2231-5691.2018.00023.0
9. Yadav AR. Mohite SK. Cancer- A Silent Killer: An Overview. Asian Journal of Pharmaceutical Research 2020; 10(3):213-216. DOI: 10.5958/2231-5691.2020.00036.2
10. Dibyajyoti Saha. Tarashankar Maity. Mayukh Jana. Supradip Mandal. Cancer Treatment Strategy-An Overview. Asian Journal of Pharmacy and Technology 2011; 1(2):28-33.
11. Heudel PE. Initial Management of Advanced Ovarian Cancer. Gynaecology Obstetrics Fertility and Senolog 2019; 47(2):197-213.
12. Jayson et al. Epigenetic changes of DNA repair genes in cancer. Analytical Chemistry 2018; 87:7653–7659.
13. Guangyuan Zha. Horacio Cardenas. Daniela Matei. Ovarian Cancer- Why Lipids Matter”, Cancers (Basel) MPDI 2019; 11(12):1870. DOI: 10.3390/cancers11121870
14. Amin Ismail. Tan siew Hong. Antioxidant activity of selected commercial seaweeds. Malaysian Journal of Nutrition 2002; 8(2):167-177.
15. Agadi VV. ‘Seaweeds Manual’ 1976; 5(2): 365.
16. Alderman DJ. Michel C. Chemotherapy in aqua culture today. Chemotherapy in Aquaculture from theory to reality. International Office Epizooties 1992; 3-4.
17. Fluerence J. Chenard E. Lucon M. Determination of the nutritional value of proteins obtained from Ulva armoricana. Journal of Applied Phycology 1999; 11:231-239.
18. Kantachumpoo A. Chiraparty A. Components and Antimicrobial Activity of Polysaccharides extracted from Thai Brown Seaweeds. Kasetsart Journal of Natural Sciences 2010; 44(2): 220-233.
19. Rodriguezum AG. Portilla CJ. Bañuelos TO. Zepeda RC. Anticancer activity of seaweeds. Drug discover today 2017; 23(2):434-447. Doi: 10.1016/j.drudis.2017.10.019.
20. Savithramma N. Linga RM. Bhumi G. Phytochemical screening of Thespesia populnea [L.] Soland and Tridax procumbens [L.] Journal of Chemical and Pharmaceutical Research 2011; 3 (5): 28-34.